Immupharma plc (IMM)

 

Latest News

ImmuPharma raises GBP8.3m via placing

ImmuPharma has conditionally raised GBP8.3 million by way of the placing of 14,901,800 new ordinary shares of 10 pence ...

Placing and Subscription Raises £8.3 million

RNS Number: 2521O Immupharma PLC 05 February 2016 5 FEBRUARY 2016 ImmuPharma PLC Placing and Subscription Raises 8.3 million ImmuPharma PLC (LSE:IMM) (" ImmuPharma " or the " Company "), the specialist drug discovery and development company, is pleased to announce the successful completion of the conditional fund raise, comprising the ...

ImmuPharma fundraising to finance Lupuzor trial

ImmuPharma has announced a proposed conditional fund raise of not less than GBP7.5 million.

Proposed Placing and Subscription

RNS Number: 1869O Immupharma PLC 05 February 2016 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, J...

All News

DateHeadlineSource
05-02-16ImmuPharma raises GBP8.3m via placingStockMarketWire
05-02-16Placing and Subscription Raises £8.3 millionRNS
05-02-16ImmuPharma fundraising to finance Lupuzor trial StockMarketWire
05-02-16Proposed Placing and SubscriptionRNS
21-01-16Holding(s) in CompanyRNS
15-12-15ImmuPharma update on Lupuzor StockMarketWire
15-12-15ImmuPharma & Simbec-Orion - Investigators MeetingRNS
08-12-15Should You Buy KAZ Minerals PLC & ImmuPharma PLC On Tuesday?Motley Fool
07-12-15ImmuPharma update on recruiting for Lupuzor trialStockMarketWire
07-12-15Update on the progress of LupuzorRNS
30-11-15Holding(s) in CompanyRNS
04-11-15Lupuzor Phase III Pivotal Trial UpdateRNS
04-11-15ImmuPharma update on Lupuzor trial StockMarketWire
04-11-15Lupuzor Phase III Pivotal Trial UpdateRNS
23-10-15ImmuPharma non-exec steps down StockMarketWire
23-10-15Directorate ChangeRNS
30-09-15Directorate ChangeRNS
30-09-15Interim ResultsRNS
29-07-15ImmuPharma chairman dies StockMarketWire
29-07-15Richard WarrRNS
27-07-15ImmuPharma clinical trials of Lupuzor 'live' StockMarketWire
27-07-15TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZORRNS
25-06-15Lupuzor founder awarded 'CNRS Medal of Innovation'StockMarketWire
25-06-15Lupuzor's Founder Dr Slyviane Muller Awarded MedalRNS
29-05-15ImmuPharma resolutions passed at AGMStockMarketWire
29-05-15Result of AGMRNS
06-05-15Annual Report & AccountsRNS
06-05-15ImmuPharma appoints interim chairman StockMarketWire
06-05-15Interim Board ChangeRNS
30-04-15ImmuPharma losses narrow StockMarketWire
30-04-15Directorate ChangeRNS
30-04-15Preliminary ResultsRNS
11-02-15Immupharma completes clinical trial StockMarketWire
11-02-15CANCER UPDATE: IPP-204106RNS
27-01-15ImmuPharma gets assurance over EIS StockMarketWire
27-01-15Enterprise Investment Scheme StatusRNS
22-01-15FTSE surges as ECB unveils QE, financials riseStockMarketWire
22-01-15FTSE cautiously up as ECB's QE call nearsStockMarketWire
22-01-15Collaboration Agreement with Simbec-OrionRNS
30-10-14Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory